Trial intelligence / Profile preview

Prednisone for Vestibular Neuronitis

NCT00271791Phase 2Completed

Sponsor
Carmel Medical Center
Start
Sep 2005
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in vestibular neuronitis comparing Prednisone with Placebo (2 arms). Primary endpoint: Presence of static and dynamic nystagmus, positional and positioning nystagmus, and disequilibrium at 12 months. Started Sep 2005; status: completed.

02

Drugs

prednisone
03

Conditions

vestibular neuronitis

Beyond the preview

Go deeper on NCT00271791.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00271791.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call